Shoulder Innovations, Inc.
SINYSECIK 1699350HealthcareFiscal year ends Dec 31
Reports and events: 26 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0811:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001699350-26-000058 |
| 2026-08-1011:09 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001699350-26-000054 |
| 2026-08-0721:08 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-26-340485 |
| 2026-08-0621:14 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001699350-26-000052 |
| 2026-08-0620:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001699350-26-000050 |
| 2026-06-2911:07 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001699350-26-000044 |
| 2026-06-2620:09 ET | 8-K | 5.07 Shareholder vote results | 0001699350-26-000042 |
| 2026-05-1320:26 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001699350-26-000035 |
| 2026-05-1320:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001699350-26-000033 |
| 2026-04-2912:38 ET | DEF 14A | Proxy statementPeriod 2026-06-26 | 0001699350-26-000026 |
| 2026-04-2711:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001699350-26-000021 |
| 2026-04-1420:31 ET | 8-K | 1.01 Entry into a material agreement | 0001699350-26-000016 |
| 2026-03-1020:20 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001699350-26-000011 |
| 2026-03-1020:09 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001699350-26-000010 |
| 2026-03-0212:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001699350-26-000003 |
| 2025-12-0312:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001699350-25-000020 |
| 2025-11-1221:10 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001699350-25-000017 |
| 2025-11-1214:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001699350-25-000015 |
| 2025-09-0920:12 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001699350-25-000011 |
| 2025-09-0911:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001699350-25-000008 |
| 2025-08-0522:49 ET | SCHEDULE 13D | Ownership report, active investor | 0000950170-25-103320 |
| 2025-08-0420:09 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001628280-25-037418 |
| 2025-07-2516:29 ET | S-1/A | Registration statement, amended | 0001628280-25-036019 |
| 2025-07-2411:00 ET | S-1/A | Registration statement, amended | 0001628280-25-035833 |
| 2025-07-0921:17 ET | S-1/A | Registration statement, amended | 0001628280-25-034668 |
| 2025-07-0721:22 ET | S-1 | Registration statement | 0001628280-25-034437 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.